Capital Asset Advisory Services LLC Blueprint Medicines Corp Put Options Transaction History
Capital Asset Advisory Services LLC
- $1.94 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
399Shares Held
65.1MCall Options Held
1.62MPut Options Held
1.43M-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$676 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$552 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$313 Million0.05% of portfolio
-
Jpmorgan Chase & CO New York, NY2.51MShares$255 Million0.02% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...